生物谷
(920266)
| 流通市值：9.15亿 | | | 总市值：9.57亿 |
| 流通股本：1.18亿 | | | 总股本：1.24亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 94,694,477.82 | 432,995,308.51 | 304,011,258.04 | 207,571,938.26 |
| 营业收入 | 94,694,477.82 | 432,995,308.51 | 304,011,258.04 | 207,571,938.26 |
| 二、营业总成本 | 99,824,794.56 | 475,523,555.5 | 340,773,972.13 | 238,588,994.29 |
| 营业成本 | 33,888,828.99 | 168,356,437.17 | 122,693,097.38 | 87,077,703.61 |
| 税金及附加 | 2,173,813.46 | 8,472,871.69 | 6,039,296.88 | 4,127,337.88 |
| 销售费用 | 42,768,847.02 | 213,939,815.88 | 145,044,231.18 | 102,108,716.69 |
| 管理费用 | 19,702,588.8 | 77,300,437.98 | 57,297,613.01 | 37,771,928.29 |
| 研发费用 | 1,022,585.8 | 5,589,342.71 | 8,531,145.84 | 6,680,191.47 |
| 财务费用 | 268,130.49 | 1,864,650.07 | 1,168,587.84 | 823,116.35 |
| 其中:利息费用 | 286,260.71 | 2,350,095.49 | 1,641,776.96 | 1,195,505.82 |
| 其中:利息收入 | 23,318.19 | 504,719.32 | 488,646.7 | 383,518.89 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | -1,822,009.61 | - | 677,990.39 |
| 加:投资收益 | -37,137.53 | 309,477.42 | 919,348.05 | 99,902.68 |
| 资产处置收益 | - | 935,245.92 | 886,020.43 | 739,105.08 |
| 资产减值损失(新) | -215,928.28 | -73,545.34 | 287,858.47 | 519,289.98 |
| 信用减值损失(新) | -343,242.65 | -4,019,239.15 | -2,424,215.71 | -1,303,511.28 |
| 其他收益 | 1,002,462.71 | 4,666,679.94 | 3,474,742.01 | 3,611,093.42 |
| 四、营业利润 | -4,724,162.49 | -42,531,637.81 | -33,618,960.84 | -26,673,185.76 |
| 加:营业外收入 | 81.71 | 61.76 | 335.44 | 274.06 |
| 减:营业外支出 | 131.45 | 5,682,501.75 | 293,236.16 | 292,782.89 |
| 五、利润总额 | -4,724,212.23 | -48,214,077.8 | -33,911,861.56 | -26,965,694.59 |
| 减:所得税费用 | -29,027.24 | 3,363,687.63 | 1,596,805.65 | 1,379,831.55 |
| 六、净利润 | -4,695,184.99 | -51,577,765.43 | -35,508,667.21 | -28,345,526.14 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -4,695,184.99 | -51,577,765.43 | -35,508,667.21 | -28,345,526.14 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -4,695,184.99 | -51,577,765.43 | -35,508,667.21 | -28,345,526.14 |
| 扣除非经常损益后的净利润 | -5,515,669.11 | -49,961,935.22 | -39,747,795.51 | -32,455,771.47 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.04 | -0.42 | -0.29 | -0.23 |
| (二)稀释每股收益 | - | -0.42 | -0.29 | -0.23 |
| 九、综合收益总额 | -4,695,184.99 | -51,577,765.43 | -35,508,667.21 | -28,345,526.14 |
| 归属于母公司股东的综合收益总额 | - | -51,577,765.43 | -35,508,667.21 | -28,345,526.14 |
| 公告日期 | 2026-04-28 | 2026-04-28 | 2025-10-29 | 2025-08-21 |
| 审计意见(境内) | | 标准无保留意见 | | |